Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
3.58M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
1.21M
-
Shares change
-
+248K
-
Total reported value, excl. options
-
$4.44M
-
Value change
-
+$906K
-
Number of buys
-
8
-
Number of sells
-
-6
-
Price
-
$3.66
Significant Holders of KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX) as of Q3 2024
20 filings reported holding KPRX - KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value as of Q3 2024.
KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.21M shares
of 3.58M outstanding shares and own 33.9% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (256K shares), Nantahala Capital Management, LLC (211K shares), Stonepine Capital Management, LLC (202K shares), ADAR1 Capital Management, LLC (197K shares), Alyeska Investment Group, L.P. (181K shares), Velan Capital Investment Management LP (122K shares), GEODE CAPITAL MANAGEMENT, LLC (14.5K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (11.4K shares), CITADEL ADVISORS LLC (10.1K shares), and SABBY MANAGEMENT, LLC (5K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.